National Cancer Institute Grant: Accelerating Pediatric Cancer Adoptive Cellular Therapy through Can-ACT Network
SynopsisVersion HistoryRelated DocumentsPackage The National Cancer Institute (NCI) is offering a grant through its new Cancer Adoptive Cellular Therapy (Can-ACT) Network initiative. This grant is for accelerating the development and clinical testing of innovative cell therapy strategies, particularly for pediatric and adult solid tumors. The NCI aims to stimulate early-phase adoptive cellular therapy clinical trials by supporting multi-investigator teams. Emphasis is placed on collaborative approaches to preclinical and translational studies, enabling [...]